CVS Health (CVS) Tops Q2 EPS by 22c, Sales Beat; Raises Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $79.96 -12.53%
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
ARIS, COHR, ATS, More
Financial Fact:
Operating expenses: 4.68B
Today's EPS Names:
ARIS, COHR, ATS, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.40, $0.22 better than the analyst estimate of $2.18. Revenue for the quarter came in at $80.6 billion versus the consensus estimate of $76.4 billion.
GUIDANCE:
CVS Health sees FY2022 EPS of $8.40-$8.60, versus prior of $8.20-$8.40 and the consensus of $8.36.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
- Amcor plc (AMCR) Misses Q1 EPS by 9c
- 8x8, Inc. (EGHT) Reports In-Line Q2 EPS
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
